BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years

MLA

Laura D, Zambrano, et al. “BNT162b2 MRNA Vaccination Against COVID-19 Is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, May 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........24a1e056558d7b405c507cfe2aa2cdde&authtype=sso&custid=ns315887.

APA

Laura D, Z., Margaret M, N., Samantha M, O., Natasha B, H., Ashley M, P., Amber O, O., Cameron C, Y., Julie A, B., Leila C, S., Aline B, M., Katherine E, B., Satoshi, K., Keiko M, T., Kathleen, C., Jennifer E, S., Melissa L, C., Sabrina M, H., Charlotte V, H., Ryan A, N., … Adrienne G, R. (2022). BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America.

Chicago

Laura D, Zambrano, Newhams Margaret M, Olson Samantha M, Halasa Natasha B, Price Ashley M, Orzel Amber O, Young Cameron C, et al. 2022. “BNT162b2 MRNA Vaccination Against COVID-19 Is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........24a1e056558d7b405c507cfe2aa2cdde&authtype=sso&custid=ns315887.